Activities of Faropenem, an Oral β-Lactam, against Recent U.S. Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

The in vitro activities of faropenem and other antimicrobial agents were determined against 4,725 Streptococcus pneumoniae isolates, 2,614 Haemophilus influenzae isolates, and 1,193 Moraxella catarrhalis isolates collected from 273 U.S. laboratories during 1999. Faropenem MICs at which 90% of isolat...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Critchley, Ian A., Karlowsky, James A., Draghi, Deborah C., Jones, Mark E., Thornsberry, Clyde, Murfitt, Kate, Sahm, Daniel F.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127058/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11796376/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.2.550-555.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!